News Image

On Wednesday, there are stocks with unusual volume. Let's take a look.

By Mill Chart

Last update: Apr 24, 2024

Unusual volume stocks in Wednesday's session

Top unusual volume stocks

TickerChangeComment
LICN47.68%LICHEN CHINA LTD- A's (NASDAQ:LICN) traded a high volume of 13.05M shares. The price of NASDAQ:LICN has increased by 47.68%, indicating upward momentum in the market. The average volume over the last 50 days is 599.93K, making today's volume 2.0K% above the average. This signifies a notable change in market participation.
POET10.76%3.9M shares of POET TECHNOLOGIES INC (NASDAQ:POET) exchanged hands today. The market is favoring NASDAQ:POET today, as its share price records a notable increase of 10.76%. Compared to the average daily volume of the past 50 days, the current volume is 2.0K% above, suggesting an unusual level of trading activity.
TLSA-2.58%The trading activity for TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA) has surged with a volume of 231.05K shares today. Shares are witnessing a downward movement, with a decrease of 2.58%. The average volume over the last 50 days is 177.82K, making today's volume 29.94% above the average. This signifies a notable change in market participation. Yesterday the company had a press release: Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program.
CYN-4.45%41.14M shares of CYNGN INC (NASDAQ:CYN) have been traded so far today. NASDAQ:CYN is showing a decline of 4.45% in today's trading. In comparison to the average daily volume of the last 50 days, the current volume is 290.0% above. This suggests a notable change in trading activity.
MTC21.43%5.95M shares of MMTEC INC (NASDAQ:MTC) have been traded so far today. Investors in NASDAQ:MTC are enjoying a price surge of 21.43% today, indicating bullish market sentiment. With an average daily volume of 1.8M over the past 50 days, today's volume is 231.0% above the average, indicating a potential shift in market sentiment. MMTEC INC released earnings Yesterday.
PEGY-10.07%With 31.31M shares traded so far, PINEAPPLE ENERGY INC (NASDAQ:PEGY) is experiencing an unusual level of activity today. The current market conditions have led to a price decrease of 10.07% for NASDAQ:PEGY. Today's trading volume is 192.0% above the average 50-day volume, indicating a significant deviation from the norm.
CSSE123.0%162.41M shares of CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) have been traded so far today. NASDAQ:CSSE is showing a positive trend today, with a price increase of 123.0%. This volume is 47.0K% above the average 50 day volume.
MTTR0.87%6.04M shares of MATTERPORT INC (NASDAQ:MTTR) exchanged hands today. The price of NASDAQ:MTTR has increased by 0.87%, indicating upward momentum in the market. The average volume over the last 50 days is 4.84M, making today's volume 24.78% above the average. This signifies a notable change in market participation. A press release (BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AGBA Group Holding Limited (Nasdaq – AGBA), Matterport, Inc. (Nasdaq – MTTR), Hibbett, Inc. (Nasdaq – HIBB)) was released yesterday.
ABEO-6.16%ABEONA THERAPEUTICS INC's (NASDAQ:ABEO) traded a high volume of 1.4M shares. Leading to a price decrease of 6.16%. Compared to the average daily volume of the past 50 days, the current volume is 192.0% above, suggesting an unusual level of trading activity. Two days ago the company had a press release: Abeona Therapeutics Provides Regulatory Update on Pz-cel.
SILO7.3%The stock of SILO PHARMA INC (NASDAQ:SILO) has caught attention with a significant volume of 313.21K shares today. NASDAQ:SILO is experiencing an advancement of 7.3% in its share price today. This is 33.06% above the average daily volume of the last 50 days. A press release (Silo Pharma Announces Positive Results for Intranasal PTSD Treatment) was released yesterday.

To see the full list of unusual volume stocks you can use our unusual volume stocks screener.

Back

SILO PHARMA INC

NASDAQ:SILO (5/8/2024, 7:18:45 PM)

Premarket: 1.7 -0.1 (-5.56%)

1.8

+0.09 (+5.26%)

SILO News

News Image15 days ago - ChartmillOn Wednesday, there are stocks with unusual volume. Let's take a look.

Unusual volume stocks in Wednesday's session

News Image16 days ago - Silo Pharma, Inc.Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
News Image16 days ago - Silo Pharma, Inc.Silo Pharma Announces Positive Results for Intranasal PTSD Treatment

Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma,...

News Imagea month ago - Silo Pharma, Inc.Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
News Imagea month ago - Silo Pharma, Inc.Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic

SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) --  Silo Pharma, Inc. (Nasdaq:...

News Image2 months ago - Silo Pharma, Inc.Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
News Image2 months ago - Silo Pharma, Inc.Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic

Exclusive license for development, manufacturing, and commercialization in process Silo Pharma to file Pre-IND in first half 2024 SARASOTA, FL, March ...

News Image2 months ago - Silo Pharma, Inc.Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
News Image2 months ago - Silo Pharma, Inc.Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain

Silo reports positive stability of SP-26 for time-release and dosage control SARASOTA, FL, March 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....

News Image2 months ago - Silo Pharma, Inc.Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
News Image2 months ago - Silo Pharma, Inc.Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD

All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024...

SILO Links
Follow us for more